🇺🇸 FDA

Intelligence Platform

Patents

Browse 2,147 pharma-relevant patents (US and EP, A61K/A61P) linked to tracked companies. Patent cliff and LOE intelligence for BD teams.

29,054 patents indexed
patent

US 10882886

Adeno-associated virus polynucleotides, polypeptides and virions

THE UNITED STATES OF AMERICA, AS REPRESENTED BY THE SECRETARY, DEPARTMENT OF HEALTH AND HUMAN SERVICES (WASHINGTON DC) · Granted Tue Jan 05 2021 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Dec 31 2040 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 10881653

Tricyclic compounds and their use in the treatment of cancer

The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Tue Jan 05 2021 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Dec 31 2040 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 10876123

Chimeric antigen receptors targeting B-cell maturation antigen

The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Tue Dec 29 2020 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Dec 24 2040 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 10876003

Class of stable heptamethine cyanine fluorophores and biomedical applications thereof

The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Tue Dec 29 2020 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Dec 24 2040 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 10875860

Azaindenoisoquinoline compounds and uses thereof

The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Tue Dec 29 2020 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Dec 24 2040 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 10869920

Construction of West Nile virus and dengue virus chimeras for use in a live virus vaccine

The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Tue Dec 22 2020 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Dec 17 2040 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 10870687

Anti-human papillomavirus 16 E7 T cell receptors

The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Tue Dec 22 2020 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Dec 17 2040 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 10869856

Substituted phenylpyrrolecarboxamides with therapeutic activity in HIV

The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Tue Dec 22 2020 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Dec 17 2040 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 10869865

Plasmodial surface anion channel inhibitors for the treatment or prevention of malaria

The United States of America, as represented by the Secretary, Department of Health and Human Serv · Granted Tue Dec 22 2020 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Dec 17 2040 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 10864285

Methods for the diagnosis and treatment of Sjögren's syndrome

The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Tue Dec 15 2020 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Dec 10 2040 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 10865389

DNA vaccines against foot-and-mouth disease virus

The Government of the United States of America, as represented by the Secretary of Homeland Security · Granted Tue Dec 15 2020 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Dec 10 2040 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 10858633

Method for producing foot-and-mouth disease virus (FMDV) viral proteins utilizing a modifi

The Government of the United States of America, as represented by the Secretary of Homeland Security · Granted Tue Dec 08 2020 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Dec 03 2040 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 10858634

Vaccines and pharmaceutical compositions against foot-and-mouth disease virus

The Government of the United States of America, as represented by the Secretary of Homeland Security · Granted Tue Dec 08 2020 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Dec 03 2040 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 10849975

Multivalent vaccines for rabies virus and filoviruses

The United States of America, as Represented by the Secretary, Department of Health and Human Services Services · Granted Tue Dec 01 2020 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Nov 26 2040 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 10849912

Method of sensitizing cancer cells to the cytotoxic effects of apoptosis inducing ligands

The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Tue Dec 01 2020 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Nov 26 2040 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 10849960

Synergistic combination of IL-4, interferon gamma, and interferon alpha in treating ovaria

The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Tue Dec 01 2020 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Nov 26 2040 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 10844387

Chimeric antigen receptors targeting B-cell maturation antigen

The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Tue Nov 24 2020 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Nov 19 2040 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 10837019

Chimeric antigen receptors targeting B-cell maturation antigen

The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Tue Nov 17 2020 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Nov 12 2040 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 10837003

Dengue tetravalent vaccine containing a common 30 nucleotide deletion in the 3′-utr of den

The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Tue Nov 17 2020 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Nov 12 2040 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 10835593

Modified anthrax toxin protective antigen

The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Tue Nov 17 2020 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Nov 12 2040 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 10836759

Thiazole derivatives useful as mutant IDH1 inhibitors for treating cancer

The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Tue Nov 17 2020 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Nov 12 2040 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 10836721

Thalidomide analogs and methods of use

The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Tue Nov 17 2020 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Nov 12 2040 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 10829769

Chimeric antigen receptors targeting b-cell maturation antigen

The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Tue Nov 10 2020 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Nov 05 2040 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 10829770

Fusion proteins containing luciferase and a polypeptide of interest

The Government of the United States of America, as represented by the Secretary of Homeland Security · Granted Tue Nov 10 2020 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Nov 05 2040 00:00:00 GMT+0000 (Coordinated Universal Time)

granted